UBS Group AG - CEMPRA INC ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of CEMPRA INC
ValueSharesWeighting
Q3 2017$56,000
+19.1%
17,101
+66.5%
0.00%
Q2 2017$47,000
+14.6%
10,270
-4.9%
0.00%
Q1 2017$41,000
-25.5%
10,802
-45.4%
0.00%
Q4 2016$55,000
-97.7%
19,797
-80.1%
0.00%
-100.0%
Q3 2016$2,402,000
+49.4%
99,237
+1.8%
0.00%0.0%
Q2 2016$1,608,000
-17.2%
97,515
-12.0%
0.00%0.0%
Q1 2016$1,941,000
-9.9%
110,784
+60.1%
0.00%0.0%
Q4 2015$2,155,000
+78.8%
69,208
+59.9%
0.00%0.0%
Q3 2015$1,205,000
-15.7%
43,273
+4.0%
0.00%0.0%
Q2 2015$1,430,000
-9.6%
41,611
-9.8%
0.00%0.0%
Q1 2015$1,582,000
+18.9%
46,111
-18.5%
0.00%0.0%
Q4 2014$1,331,00056,6100.00%
Other shareholders
CEMPRA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Aisling Capital LLC 2,193,060$68,270,00011.77%
Abingworth LLP 383,935$11,948,0007.21%
ACUTA CAPITAL PARTNERS, LLC 250,000$7,783,0003.72%
Opaleye Management Inc. 200,000$6,226,0002.60%
Knoll Capital Management, LLC 180,800$5,628,0002.09%
Palo Alto Investors LP 1,175,733$36,601,0002.04%
BB BIOTECH AG 1,991,900$62,008,0001.75%
AlpInvest Partners B.V. 31,400$977,0001.62%
GENERAL AMERICAN INVESTORS CO INC 494,409$15,391,0001.41%
HARVEY CAPITAL MANAGEMENT INC 112,250$3,494,0001.38%
View complete list of CEMPRA INC shareholders